ReviewCureus2024
The Impact of Lifestyle Intervention Programs on Long-Term Cardiac Event-Free Survival in Patients With Established Coronary Artery Disease.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Best evidence summary of digital health interventions for self-management in patients with coronary artery disease.Frontiers in public health · 2026Pooled it
- Role of exercise in cardiovascular health: a narrative review from prevention to therapeutic utilizations.Frontiers in cardiovascular medicine · 2026Review
- Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm.Reviews in cardiovascular medicine · 2025Review
- Arthrospira Platensis Attenuates Endothelial Inflammation and Monocyte Activation.International journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronary artery disease (CAD) is a leading global cause of morbidity and mortality, necessitating comprehensive approaches for its management. This systematic review evaluates the long-term impact of structured lifestyle intervention programs on cardiac event-free survival in patients with established CAD. A total of eight studies, including randomized controlled trials (RCTs) and prospective cohort studies, were analyzed, encompassing diverse interventions such as cardiac rehabilitation, dietary modifications, exercise programs, and psychosocial support. The findings indicate that lifestyle interventions significantly improve event-free survival, reduce recurrent cardiac events, and enhance overall health markers as compared to usual care. Intensive interventions, such as comprehensive cardiac rehabilitation, showed the most pronounced benefits, including regression of coronary artery stenosis measured through angiographic imaging and a reduced need for revascularization (relative risk reduction up to 45%; p < 0.05). Flexible and accessible approaches, like home-based or telephonic rehabilitation, demonstrated potential in improving adherence, measured by program completion rates and self-reported lifestyle changes, and outcomes in specific populations such as elderly or high-risk patients. Limitations include variability in intervention intensity, small sample sizes in some studies, and differences in adherence definitions and measurement methods. This review highlights the critical role of lifestyle modifications as a cornerstone of secondary prevention strategies in CAD management and suggests that technology-based and demographic-specific interventions may hold promise for improving long-term outcomes. Future research should focus on long-term sustainability and optimizing tailored intervention designs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.